Literature DB >> 9256469

Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.

S Tourne1, T Miyazaki, P Wolf, H Ploegh, C Benoist, D Mathis.   

Abstract

By combining two previously generated null mutations, Ii degrees and M degrees , we produced mice lacking the invariant chain and H-2M complexes, both required for normal cell-surface expression of major histocompatibility complex class II molecules loaded with the usual diverse array of peptides. As expected, the maturation and transport of class II molecules, their expression at the cell surface, and their capacity to present antigens were quite similar for cells from Ii degrees M degrees double-mutant mice and from animals carrying just the Ii degrees mutation. More surprising were certain features of the CD4(+) T cell repertoire selected in Ii degrees M degrees mice: many fewer cells were selected than in Ii+M degrees animals, and these had been purged of self-reactive specificities, unlike their counterparts in Ii+M degrees animals. These findings suggest (i) that the peptides carried by class II molecules on stromal cells lacking H-2M complexes may almost all derive from invariant chain and (ii) that H-2M complexes edit the peptide array displayed on thymic stromal cells in the absence of invariant chain, showing that it can edit, in vivo, peptides other than CLIP.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256469      PMCID: PMC23144          DOI: 10.1073/pnas.94.17.9255

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  54 in total

1.  Antigen presentation mediated by recycling of surface HLA-DR molecules.

Authors:  V Pinet; M Vergelli; R Martin; O Bakke; E O Long
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

2.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

3.  Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain.

Authors:  A Jasanoff; S J Park; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

4.  Invariant chain-independent antigen presentation depends primarily upon the pool of newly synthesized MHC class II molecules.

Authors:  K Swier; J Miller
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

5.  Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.

Authors:  R Busch; I Cloutier; R P Sékaly; G J Hämmerling
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

6.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.

Authors:  M A Sherman; D A Weber; P E Jensen
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

7.  Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway.

Authors:  T Miyazaki; P Wolf; S Tourne; C Waltzinger; A Dierich; N Barois; H Ploegh; C Benoist; D Mathis
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

8.  Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.

Authors:  A Oxenius; M F Bachmann; P G Ashton-Rickardt; S Tonegawa; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

9.  The influence of invariant chain on the positive selection of single T cell receptor specificities.

Authors:  S Tourne; N Nakano; S Viville; C Benoist; D Mathis
Journal:  Eur J Immunol       Date:  1995-07       Impact factor: 5.532

10.  CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  S Cardell; S Tangri; S Chan; M Kronenberg; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more
  12 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Positive selection of self-MHC-reactive T cells by individual peptide-MHC class II complexes.

Authors:  Gregory M Barton; Courtney Beers; Paul deRoos; Susan R Eastman; Marcela E Gomez; Katherine A Forbush; Alexander Y Rudensky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

3.  Purification of intracellular compartments involved in antigen processing: a new method based on magnetic sorting.

Authors:  L A Perrin-Cocon; P N Marche; C L Villiers
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

4.  A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

Authors:  H Kropshofer; A B Vogt; C Thery; E A Armandola; B C Li; G Moldenhauer; S Amigorena; G J Hämmerling
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

Review 5.  The melting pot of the MHC II peptidome.

Authors:  Lawrence J Stern; Laura Santambrogio
Journal:  Curr Opin Immunol       Date:  2016-03-25       Impact factor: 7.486

6.  Functional HLA-DM on the surface of B cells and immature dendritic cells.

Authors:  S O Arndt; A B Vogt; S Markovic-Plese; R Martin; G Moldenhauer; A Wölpl; Y Sun; D Schadendorf; G J Hämmerling; H Kropshofer
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

7.  The nonconventional MHC class II molecule DM governs diabetes susceptibility in NOD mice.

Authors:  Marc A J Morgan; Pari S S Muller; Arne Mould; Stephen A Newland; Jennifer Nichols; Elizabeth J Robertson; Anne Cooke; Elizabeth K Bikoff
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Positive selection of CD4(+) T cells is induced in vivo by agonist and inhibited by antagonist peptides.

Authors:  P Kraj; R Pacholczyk; H Ignatowicz; P Kisielow; P Jensen; L Ignatowicz
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

9.  DM determines the cryptic and immunodominant fate of T cell epitopes.

Authors:  N K Nanda; A J Sant
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

10.  Cathepsin L regulates CD4+ T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands.

Authors:  Karen Honey; Terry Nakagawa; Christoph Peters; Alexander Rudensky
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.